Beta cell apoptosis in diabetes

Apoptosis

Volumn 14, Issue 12, 2009, Pages 1389-1404

  Thomas, Helen E ^a,b   McKenzie, Mark D ^a,b   Angstetra, Eveline ^a,b   Campbell, Peter D ^a,b   Kay, Thomas W ^a,b  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Apoptosis; Diabetes; Islet transplantation; Pancreatic beta cells

Indexed keywords

APOPTOSIS; DIABETES MELLITUS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW;

ANIMALS; APOPTOSIS; DIABETES MELLITUS; GRAFT REJECTION; HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS TRANSPLANTATION;

EID: 70449105119     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-009-0339-5     Document Type: Review

References (207)

1. P Augstein AG Elefanty J Allison, et al. 1998 Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes Diabetologia 41 1381 1388 10.1007/s001250051080 9833948 (Pubitemid 28488768)
2. AE Butler J Janson S Bonner-Weir, et al. 2003 Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes Diabetes 52 102 110 10.2337/diabetes.52.1.102 12502499 (Pubitemid 36042113)
3. MO Kurrer SV Pakala HL Hanson, et al. 1997 Beta cell apoptosis in T cell-mediated autoimmune diabetes Proc Natl Acad Sci USA 94 213 218 10.1073/pnas.94.1.213 8990188 (Pubitemid 27027189)
4. BA O'Brien BV Harmon DP Cameron, et al. 1997 Apoptosis is the mode of beta-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse Diabetes 46 750 757 10.2337/diabetes.46.5.750 9133540
5. M Cnop N Welsh JC Jonas, et al. 2005 Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities Diabetes 54 Suppl 2 S97 S107 10.2337/diabetes.54.suppl-2.S97 16306347 (Pubitemid 43343337)
6. AK Foulis MA Farquharson R Hardman 1987 Aberrant expression of class II major histocompatibility complex molecules by B cells and hyperexpression of class I major histocompatibility complex molecules by insulin containing islets in type 1 (insulin-dependent) diabetes mellitus Diabetologia 30 333 343 10.1007/BF00299027 3301484 (Pubitemid 17083703)
7. GF Bottazzo BM Dean JM McNally, et al. 1985 In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis N Engl J Med 313 353 360 3159965
8. A Hanninen S Jalkanen M Salmi, et al. 1992 Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus J Clin Invest 90 1901 1910 10.1172/JCI116067 1385478
9. N Itoh T Hanafusa A Miyazaki, et al. 1993 Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients J Clin Invest 92 2313 2322 10.1172/JCI116835 8227346
10. M Moriwaki N Itoh J Miyagawa, et al. 1999 Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset type I diabetes mellitus Diabetologia 42 1332 1340 10.1007/s001250051446 10550417 (Pubitemid 29500970)
11. P Santamaria RE Nakhleh DE Sutherland, et al. 1992 Characterization of T lymphocytes infiltrating human pancreas allograft affected by isletitis and recurrent diabetes Diabetes 41 53 61 10.2337/diabetes.41.1.53 1309355
12. RK Sibley DE Sutherland F Goetz, et al. 1985 Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases Lab Invest 53 132 144 3894793
13. D Dubois-LaForgue JC Carel PF Bougneres, et al. 1999 T-cell response to proinsulin and insulin in type 1 and pretype 1 diabetes J Clin Immunol 19 127 134 10.1023/A:1020558601175 10226887
14. Y Hassainya F Garcia-Pons R Kratzer, et al. 2005 Identification of naturally processed HLA-A2-restricted proinsulin epitopes by reverse immunology Diabetes 54 2053 2059 10.2337/diabetes.54.7.2053 15983206 (Pubitemid 40911268)
15. R Mallone E Martinuzzi P Blancou, et al. 2007 CD8+T-cell responses identify beta-cell autoimmunity in human type 1 diabetes Diabetes 56 613 621 10.2337/db06-1419 17327428 (Pubitemid 46348452)
16. Q Ouyang NE Standifer H Qin, et al. 2006 Recognition of HLA class I-restricted beta-cell epitopes in type 1 diabetes Diabetes 55 3068 3074 10.2337/db06-0065 17065344 (Pubitemid 44923644)
17. P Panina-Bordignon R Lang PM van Endert, et al. 1995 Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes J Exp Med 181 1923 1927 10.1084/jem.181.5.1923 7722468
18. GG Pinkse OH Tysma CA Bergen, et al. 2005 Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes Proc Natl Acad Sci USA 102 18425 18430 10.1073/pnas.0508621102 16339897 (Pubitemid 43011242)
19. A Toma S Haddouk JP Briand, et al. 2005 Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients Proc Natl Acad Sci USA 102 10581 10586 10.1073/pnas.0504230102 16030147 (Pubitemid 41061597)
20. J Katz C Benoist D Mathis 1993 Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice Eur J Immunol 23 3358 3360 10.1002/eji.1830231244 8258349 (Pubitemid 23353790)
21. DV Serreze EH Leiter GJ Christianson, et al. 1994 Major histocompatibility complex class I-deficient NOD-beta 2-m null mice are diabetes and insulitis resistant Diabetes 43 505 509 10.2337/diabetes.43.3.505 8314025
22. T Sumida M Furukawa A Sakamoto, et al. 1994 Prevention of insulitis and diabetes in beta 2-microglobulin-deficient non-obese diabetic mice Int Immunol 6 1445 1449 10.1093/intimm/6.9.1445 7819154
23. LS Wicker EH Leiter JA Todd, et al. 1994 Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes Diabetes 43 500 504 10.2337/diabetes.43.3.500 8314024
24. EE Hamilton-Williams SE Palmer B Charlton, et al. 2003 Beta cell MHC class I is a late requirement for diabetes Proc Natl Acad Sci USA 100 6688 6693 10.1073/pnas.1131954100 12750472 (Pubitemid 36666642)
25. RT Graser TP DiLorenzo F Wang, et al. 2000 Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions J Immunol 164 3913 3918 10725754
26. J Verdaguer D Schmidt A Amrani, et al. 1997 Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice J Exp Med 186 1663 1676 10.1,084/jem.186.10.1,663 9362527
27. FS Wong I Visintin L Wen, et al. 1996 CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells J Exp Med 183 67 76 10.1,084/jem.183.1.67 8551245
28. P De Berardinis M Londei M Kahan, et al. 1988 The majority of the activated T cells in the blood of insulin-dependent diabetes mellitus (IDDM) patients are CD4+ Clin Exp Immunol 73 255 259 2972427
29. JD Katz B Wang K Haskins, et al. 1993 Following a diabetogenic T cell from genesis through pathogenesis Cell 74 1089 1100 10.1,016/0,092-8,674(93)90, 730-E 8402882
30. C Mora FS Wong CH Chang, et al. 1999 Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice J Immunol 162 4576 4588 10201997
31. FS Wong I Visintin L Wen, et al. 1998 The role of lymphocyte subsets in accelerated diabetes in nonobese diabetic-rat insulin promoter-B7-1 (NOD-RIP-B7-1) mice J Exp Med 187 1985 1993 10.1,084/jem.187.12.1,985 9625758
32. D Kagi B Odermatt P Seiler, et al. 1997 Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice J Exp Med 186 989 997 10.1,084/jem.186.7.989 9314549
33. B Wang A Gonzalez C Benoist, et al. 1996 The role of CD8+T cells in the initiation of insulin-dependent diabetes mellitus Eur J Immunol 26 1762 1769 10.1,002/eji.1,830,260,815 8765018
34. SW Christianson LD Shultz EH Leiter 1993 Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+and CD8+T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors Diabetes 42 44 55 10.2,337/diabetes.42.1.44 8093606
35. JD Peterson K Haskins 1996 Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells Diabetes 45 328 336 10.2,337/diabetes.45.3.328 8593938
36. SP Cullen SJ Martin 2008 Mechanisms of granule-dependent killing Cell Death Differ 15 251 262 10.1,038/sj.cdd.4,402,244 17975553
37. JA Trapani MJ Smyth 2002 Functional significance of the perforin/granzyme cell death pathway Nat Rev Immunol 2 735 747 10.1,038/nri911 12360212
38. NL Dudek HE Thomas L Mariana, et al. 2006 Cytotoxic T-cells from T-cell receptor transgenic NOD8.3 mice destroy beta-cells via the perforin and Fas pathways Diabetes 55 2412 2418 10.2,337/db06-0,109 16936188
39. HT Kreuwel DJ Morgan T Krahl, et al. 1999 Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+T cell-mediated insulin-dependent diabetes mellitus J Immunol 163 4335 4341 10510373
40. MD McKenzie NL Dudek L Mariana, et al. 2006 Perforin and Fas induced by IFNgamma and TNFalpha mediate beta cell death by OT-I CTL Int Immunol 18 837 846 10.1,093/intimm/dxl020 16574667
41. PD Campbell E Estella NL Dudek, et al. 2008 Cytotoxic T-lymphocyte-mediated killing of human pancreatic islet cells in vitro Hum Immunol 69 543 551 10.1,016/j.humimm.2,008.06.008 18639598
42. A Amrani J Verdaguer B Anderson, et al. 1999 Perforin-independent beta-cell destruction by diabetogenic CD8(+) T lymphocytes in transgenic nonobese diabetic mice J Clin Invest 103 1201 1209 10.1,172/JCI6266 10207172
43. VR Sutton JE Davis M Cancilla, et al. 2000 Initiation of apoptosis by granzyme B requires direct cleavage of bid, but not direct granzyme B-mediated caspase activation J Exp Med 192 1403 1414 10.1,084/jem.192.10.1,403 11085743
44. A Strasser 2005 The role of BH3-only proteins in the immune system Nat Rev Immunol 5 189 200 10.1,038/nri1568 15719025
45. E Estella MD McKenzie T Catterall, et al. 2006 Granzyme B-mediated death of pancreatic beta-cells requires the proapoptotic BH3-only molecule bid Diabetes 55 2212 2219 10.2,337/db06-0,129 16873683
46. H Wajant 2002 The Fas signaling pathway: more than a paradigm Science 296 1635 1636 10.1,126/science.1,071,553 12040174
47. T Suda T Takahashi P Golstein, et al. 1993 Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family Cell 75 1169 1178 10.1,016/0,092-8,674(93)90,326-L 7505205
48. R Watanabe-Fukunaga CI Brannan N Itoh, et al. 1992 The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen J Immunol 148 1274 1279 1371136
49. P Waring A Mullbacher 1999 Cell death induced by the Fas/Fas ligand pathway and its role in pathology Immunol Cell Biol 77 312 317 10.1,046/j.1,440-1711.1,999.00837.x 10457197
50. F Rieux-Laucat F Le Deist C Hivroz, et al. 1995 Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity Science 268 1347 1349 10.1126/science.7539157 7539157
51. R Watanabe-Fukunaga CI Brannan NG Copeland, et al. 1992 Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis Nature 356 314 317 10.1038/356314a0 1372394
52. JB Roths ED Murphy EM Eicher 1984 A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice J Exp Med 159 1 20 10.1084/jem.159.1.1 6693832
53. MC Sneller J Wang JK Dale, et al. 1997 Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis Blood 89 1341 1348 9028957
54. W Suarez-Pinzon O Sorensen RC Bleackley, et al. 1999 Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets Diabetes 48 21 28 10.2337/diabetes.48.1.21 9892218 (Pubitemid 29019348)
55. HE Thomas R Darwiche JA Corbett, et al. 1999 Evidence that beta cell death in the nonobese diabetic mouse is Fas independent J Immunol 163 1562 1569 10415060
56. K Yamada N Takane-Gyotoku X Yuan, et al. 1996 Mouse islet cell lysis mediated by interleukin-1-induced Fas Diabetologia 39 1306 1312 10.1007/s001250050574 8932996 (Pubitemid 26356058)
57. AC Loweth GT Williams RF James, et al. 1998 Human islets of langerhans express Fas ligand and undergo apoptosis in response to interleukin-1beta and Fas ligation Diabetes 47 727 732 10.2337/diabetes.47.5.727 9588443 (Pubitemid 28201801)
58. E Angstetra KL Graham S Emmett, et al. 2009 In vivo effects of cytokines on pancreatic beta-cells in models of type I diabetes dependent on CD4(+) T lymphocytes Immunol Cell Biol 87 178 185 10.1038/icb.2008.81 19015667
59. R Darwiche MM Chong P Santamaria, et al. 2003 Fas is detectable on beta cells in accelerated, but not spontaneous, diabetes in nonobese diabetic mice J Immunol 170 6292 6297 12794162
60. G Stassi M Todaro P Richiusa, et al. 1995 Expression of apoptosis-inducing CD95 (Fas/Apo-1) on human beta-cells sorted by flow-cytometry and cultured in vitro Transpl Proc 27 3271 3275
61. N Liadis L Salmena E Kwan, et al. 2007 Distinct in vivo roles of caspase-8 in beta-cells in physiological and diabetes models Diabetes 56 2302 2311 10.2337/db06-1771 17563067 (Pubitemid 47358237)
62. MD McKenzie EM Carrington T Kaufmann, et al. 2008 Proapoptotic BH3-only protein Bid is essential for death receptor-induced apoptosis of pancreatic beta-cells Diabetes 57 1284 1292 10.2337/db07-1692 18252892
63. A Amrani J Verdaguer S Thiessen, et al. 2000 IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes J Clin Invest 105 459 468 10.1172/JCI8185 10683375
64. I Apostolou Z Hao K Rajewsky, et al. 2003 Effective destruction of Fas-deficient insulin-producing beta cells in type 1 diabetes J Exp Med 198 1103 1106 10.1084/jem.20030698 14530378 (Pubitemid 37248625)
65. AY Savinov A Tcherepanov EA Green, et al. 2003 Contribution of Fas to diabetes development Proc Natl Acad Sci USA 100 628 632 10.1073/pnas.0237359100 12525697 (Pubitemid 36126103)
66. J Allison HE Thomas T Catterall, et al. 2005 Transgenic expression of dominant-negative Fas-associated death domain protein in beta cells protects against Fas ligand-induced apoptosis and reduces spontaneous diabetes in nonobese diabetic mice J Immunol 175 293 301 15972661
67. J Allison A Strasser 1998 Mechanisms of beta cell death in diabetes: a minor role for CD95 Proc Natl Acad Sci USA 95 13818 13822 10.1073/pnas.95.23. 13818 9811884 (Pubitemid 28523056)
68. SV Pakala M Chivetta CB Kelly, et al. 1999 In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha J Exp Med 189 1053 1062 10.1084/jem.189.7.1053 10190896 (Pubitemid 29169822)
69. AV Chervonsky Y Wang FS Wong, et al. 1997 The role of Fas in autoimmune diabetes Cell 89 17 24 10.1016/S0092-8674(00)80178-6 9094710
70. N Itoh A Imagawa T Hanafusa, et al. 1997 Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice J Exp Med 186 613 618 10.1084/jem.186.4.613 9254659 (Pubitemid 27360805)
71. MS Anderson JA Bluestone 2005 The NOD mouse: a model of immune dysregulation Annu Rev Immunol 23 447 485 10.1146/annurev.immunol.23.021704. 115643 15771578 (Pubitemid 40563177)
72. AS Mohamood ML Guler Z Xiao, et al. 2007 Protection from autoimmune diabetes and T-cell lymphoproliferation induced by FasL mutation are differentially regulated and can be uncoupled pharmacologically Am J Pathol 171 97 106 10.2353/ajpath.2007.070148 17591957 (Pubitemid 47339230)
73. M Nakayama M Nagata H Yasuda, et al. 2002 Fas/Fas ligand interactions play an essential role in the initiation of murine autoimmune diabetes Diabetes 51 1391 1397 10.2337/diabetes.51.5.1391 11978635
74. WL Suarez-Pinzon RF Power A Rabinovitch 2000 Fas ligand-mediated mechanisms are involved in autoimmune destruction of islet beta cells in non-obese diabetic mice Diabetologia 43 1149 1156 10.1007/s001250051506 11043861 (Pubitemid 30702938)
75. L Vence C Benoist D Mathis 2004 Fas deficiency prevents type 1 diabetes by inducing hyporesponsiveness in islet beta-cell-reactive T-cells Diabetes 53 2797 2803 10.2337/diabetes.53.11.2797 15504959 (Pubitemid 39425904)
76. T Mandrup-Poulsen K Bendtzen J Nerup, et al. 1986 Affinity-purified human interleukin I is cytotoxic to isolated islets of langerhans Diabetologia 29 63 67 10.1007/BF02427283 3514344 (Pubitemid 16162744)
77. T Mandrup-Poulsen K Bendtzen JH Nielsen, et al. 1985 Cytokines cause functional and structural damage to isolated islets of langerhans Allergy 40 424 429 10.1111/j.1398-9995.1985.tb02681.x 3901813
78. T Mandrup-Poulsen 1996 The role of interleukin-1 in the pathogenesis of IDDM Diabetologia 39 1005 1029 10.1007/BF00400649 8877284
79. M Arnush MR Heitmeier AL Scarim, et al. 1998 IL-1 produced and released endogenously within human islets inhibits beta cell function J Clin Invest 102 516 526 10.1172/JCI844 9691088
80. HE Thomas R Darwiche JA Corbett, et al. 2002 Interleukin-1 plus gamma-interferon-induced pancreatic beta-cell dysfunction is mediated by beta-cell nitric oxide production Diabetes 51 311 316 10.2337/diabetes.51.2.311 11812737
81. Z Dogusan M Garcia D Flamez, et al. 2008 Double-stranded RNA induces pancreatic beta-cell apoptosis by activation of the toll-like receptor 3 and interferon regulatory factor 3 pathways Diabetes 57 1236 1245 10.2337/db07-0844 18223009
82. MI Darville DL Eizirik 1998 Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells Diabetologia 41 1101 1108 10.1007/s001250051036 9754830 (Pubitemid 28394417)
83. MM Chong HE Thomas TW Kay 2001 Gamma-interferon signaling in pancreatic beta-cells is persistent but can be terminated by overexpression of suppressor of cytokine signaling-1 Diabetes 50 2744 2751 10.2337/diabetes.50.12.2744 11723057
84. HE Thomas E Angstetra RV Fernandes, et al. 2006 Perturbations in nuclear factor-kappaB or c-Jun N-terminal kinase pathways in pancreatic beta cells confer susceptibility to cytokine-induced cell death Immunol Cell Biol 84 20 27 10.1111/j.1440-1711.2005.01397.x 16277639
85. A Ammendrup A Maillard K Nielsen, et al. 2000 The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic beta-cells Diabetes 49 1468 1476 10.2337/diabetes.49.9.1468 10969830
86. C Bonny A Oberson S Negri, et al. 2001 Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death Diabetes 50 77 82 10.2337/diabetes.50. 1.77 11147798
87. C Bonny A Oberson M Steinmann, et al. 2000 IB1 reduces cytokine-induced apoptosis of insulin-secreting cells J Biol Chem 275 16466 16472 10.1074/jbc.M908297199 10748095 (Pubitemid 30398867)
88. M Ferdaoussi S Abdelli JY Yang, et al. 2008 Exendin-4 protects beta-cells from interleukin-1 beta-induced apoptosis by interfering with the c-Jun NH2-terminal kinase pathway Diabetes 57 1205 1215 10.2337/db07-1214 18252896
89. L Li W El-Kholy CJ Rhodes, et al. 2005 Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B Diabetologia 48 1339 1349 10.1007/s00125-005-1787-2 15902400 (Pubitemid 41186100)
90. MM Chong HE Thomas TW Kay 2002 Suppressor of cytokine signaling-1 regulates the sensitivity of pancreatic beta cells to tumor necrosis factor J Biol Chem 277 27945 27952 10.1074/jbc.M110214200 12032139 (Pubitemid 34966742)
91. J Saldeen JC Lee N Welsh 2001 Role of p38 mitogen-activated protein kinase (p38 MAPK) in cytokine-induced rat islet cell apoptosis Biochem Pharmacol 61 1561 1569 10.1016/S0006-2952(01)00605-0 11377386 (Pubitemid 32476910)
92. EA Green EE Eynon RA Flavell 1998 Local expression of TNFalpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens Immunity 9 733 743 10.1016/S1074-7613(00)80670-6 9846494
93. Y Higuchi P Herrera P Muniesa, et al. 1992 Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes J Exp Med 176 1719 1731 10.1084/jem.176.6.1719 1460428
94. DE Picarella A Kratz CB Li, et al. 1993 Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice J Immunol 150 4136 4150 7682590
95. AA Beg D Baltimore 1996 An essential role for NF-kappaB in preventing TNF-alpha-induced cell death Science 274 782 784 10.1126/science.274.5288.782 8864118 (Pubitemid 26398258)
96. MS Baker X Chen XC Cao, et al. 2001 Expression of a dominant negative inhibitor of NF-kappaB protects MIN6 beta-cells from cytokine-induced apoptosis J Surg Res 97 117 122 10.1006/jsre.2001.6121 11341786 (Pubitemid 34948479)
97. N Giannoukakis WA Rudert M Trucco, et al. 2000 Protection of human islets from the effects of interleukin-1beta by adenoviral gene transfer of an Ikappa B repressor J Biol Chem 275 36509 36513 10.1074/jbc.M005943200 10967112 (Pubitemid 32002047)
98. H Heimberg Y Heremans C Jobin, et al. 2001 Inhibition of cytokine-induced NF-kappaB activation by adenovirus-mediated expression of a NF-kappaB super-repressor prevents beta-cell apoptosis Diabetes 50 2219 2224 10.2337/diabetes.50.10.2219 11574401
99. I Chang S Kim JY Kim, et al. 2003 Nuclear factor kappaB protects pancreatic beta-cells from tumor necrosis factor-alpha-mediated apoptosis Diabetes 52 1169 1175 10.2337/diabetes.52.5.1169 12716748 (Pubitemid 36523352)
100. D Liuwantara M Elliot MW Smith, et al. 2006 Nuclear factor-kappaB regulates beta-cell death: a critical role for A20 in beta-cell protection Diabetes 55 2491 2501 10.2337/db06-0142 16936197 (Pubitemid 44871149)
101. LA Stephens HE Thomas L Ming, et al. 1999 Tumor necrosis factor-alpha-activated cell death pathways in NIT-1 insulinoma cells and primary pancreatic beta cells Endocrinology 140 3219 3227 10.1210/en.140.7.3219 10385418
102. S Kim I Millet HS Kim, et al. 2007 NF-kappa B prevents beta cell death and autoimmune diabetes in NOD mice Proc Natl Acad Sci USA 104 1913 1918 10.1073/pnas.0610690104 17267600 (Pubitemid 46239878)
103. R Eldor A Yeffet K Baum, et al. 2006 Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents Proc Natl Acad Sci USA 103 5072 5077 10.1073/pnas.0508166103 16551748
104. CA Gysemans L Ladriere H Callewaert, et al. 2005 Disruption of the gamma-interferon signaling pathway at the level of signal transducer and activator of transcription-1 prevents immune destruction of beta-cells Diabetes 54 2396 2403 10.2337/diabetes.54.8.2396 16046307 (Pubitemid 41134268)
105. S Kim HS Kim KW Chung, et al. 2007 Essential role for signal transducer and activator of transcription-1 in pancreatic beta-cell death and autoimmune type 1 diabetes of nonobese diabetic mice Diabetes 56 2561 2568 10.2337/db06-1372 17620422 (Pubitemid 47523264)
106. ST Grey MB Arvelo W Hasenkamp, et al. 1999 A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets J Exp Med 190 1135 1146 10.1084/jem.190.8.1135 10523611 (Pubitemid 29496506)
107. HS Kim S Kim MS Lee 2005 IFN-gamma sensitizes MIN6N8 insulinoma cells to TNF-alpha-induced apoptosis by inhibiting NF-kappaB-mediated XIAP upregulation Biochem Biophys Res Commun 336 847 853 10.1016/j.bbrc.2005.08.183 16154537 (Pubitemid 41338346)
108. JA Emamaullee RV Rajotte P Liston, et al. 2005 XIAP overexpression in human islets prevents early posttransplant apoptosis and reduces the islet mass needed to treat diabetes Diabetes 54 2541 2548 10.2337/diabetes.54.9.2541 16123341 (Pubitemid 41233574)
109. A Plesner P Liston R Tan, et al. 2005 The X-linked inhibitor of apoptosis protein enhances survival of murine islet allografts Diabetes 54 2533 2540 10.2337/diabetes.54.9.2533 16123340 (Pubitemid 41235478)
110. HE Thomas W Irawaty R Darwiche, et al. 2004 IL-1 receptor deficiency slows progression to diabetes in the NOD mouse Diabetes 53 113 121 10.2337/diabetes.53.1.113 14693705 (Pubitemid 38044705)
111. C Cailleau A Diu-Hercend E Ruuth, et al. 1997 Treatment with neutralizing antibodies specific for IL-1beta prevents cyclophosphamide-induced diabetes in nonobese diabetic mice Diabetes 46 937 940 10.2337/diabetes.46.6.937 9166662
112. F Nicoletti R Di Marco W Barcellini, et al. 1994 Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor Eur J Immunol 24 1843 1847 10.1002/eji.1830240818 8056041 (Pubitemid 24237555)
113. JO Sandberg DL Eizirik S Sandler 1997 IL-1 receptor antagonist inhibits recurrence of disease after syngeneic pancreatic islet transplantation to spontaneously diabetic non-obese diabetic (NOD) mice Clin Exp Immunol 108 314 317 10.1046/j.1365-2249.1997.3771275.x 9158104
114. BJ O'Sullivan HE Thomas S Pai, et al. 2006 IL-1 beta breaks tolerance through expansion of CD25+effector T cells J Immunol 176 7278 7287 16751371
115. D Kagi A Ho B Odermatt, et al. 1999 TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes J Immunol 162 4598 4605 10201999
116. B Hultgren X Huang N Dybdal, et al. 1996 Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice Diabetes 45 812 817 10.2337/diabetes.45.6.812 8635658
117. O Kanagawa G Xu A Tevaarwerk, et al. 2000 Protection of nonobese diabetic mice from diabetes by gene(s) closely linked to IFN-gamma receptor loci J Immunol 164 3919 3923 10725755
118. DV Serreze CM Post HD Chapman, et al. 2000 Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice Diabetes 49 2007 2011 10.2337/diabetes.49.12.2007 11118001
119. HE Thomas JL Parker RD Schreiber, et al. 1998 IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes J Clin Invest 102 1249 1257 10.1172/JCI2899 9739059
120. T Nakazawa J Satoh K Takahashi, et al. 2001 Complete suppression of insulitis and diabetes in NOD mice lacking interferon regulatory factor-1 J Autoimmun 17 119 125 10.1006/jaut.2001.0531 11591120 (Pubitemid 32928207)
121. MM Chong Y Chen R Darwiche, et al. 2004 Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8(+) T cell-mediated autoimmune destruction J Immunol 172 5714 5721 15100317
122. M Flodstrom-Tullberg D Yadav R Hagerkvist, et al. 2003 Target cell expression of suppressor of cytokine signaling-1 prevents diabetes in the NOD mouse Diabetes 52 2696 2700 10.2337/diabetes.52.11.2696 14578288 (Pubitemid 37339699)
123. M Ott V Gogvadze S Orrenius, et al. 2007 Mitochondria, oxidative stress and cell death Apoptosis 12 913 922 10.1007/s10495-007-0756-2 17453160 (Pubitemid 46653300)
124. C Guichard R Moreau D Pessayre, et al. 2008 NOX family NADPH oxidases in liver and in pancreatic islets: a role in the metabolic syndrome and diabetes? Biochem Soc Trans 36 920 929 10.1042/BST0360920 18793162
125. DL Eizirik DG Pipeleers Z Ling, et al. 1994 Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury Proc Natl Acad Sci USA 91 9253 9256 10.1073/pnas.91.20.9253 7937750
126. K Grankvist SL Marklund IB Taljedal 1981 CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse Biochem J 199 393 398 7041886
127. S Lenzen J Drinkgern M Tiedge 1996 Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues Free Radic Biol Med 20 463 466 10.1016/0891-5849(96)02051-5 8720919 (Pubitemid 26077870)
128. M Tiedge S Lortz J Drinkgern, et al. 1997 Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells Diabetes 46 1733 1742 10.2337/diabetes.46.11.1733 9356019
129. N Welsh B Margulis LA Borg, et al. 1995 Differences in the expression of heat-shock proteins and antioxidant enzymes between human and rodent pancreatic islets: implications for the pathogenesis of insulin-dependent diabetes mellitus Mol Med 1 806 820 8612203
130. X Li H Chen PN Epstein 2004 Metallothionein protects islets from hypoxia and extends islet graft survival by scavenging most kinds of reactive oxygen species J Biol Chem 279 765 771 10.1074/jbc.M307907200 14576162 (Pubitemid 38044882)
131. S Lortz M Tiedge T Nachtwey, et al. 2000 Protection of insulin-producing RINm5F cells against cytokine-mediated toxicity through overexpression of antioxidant enzymes Diabetes 49 1123 1130 10.2337/diabetes.49.7.1123 10909968
132. H Chen X Li PN Epstein 2005 MnSOD and catalase transgenes demonstrate that protection of islets from oxidative stress does not alter cytokine toxicity Diabetes 54 1437 1446 10.2337/diabetes.54.5.1437 15855331 (Pubitemid 40586675)
133. TB Mysore TA Shinkel J Collins, et al. 2005 Overexpression of glutathione peroxidase with two isoforms of superoxide dismutase protects mouse islets from oxidative injury and improves islet graft function Diabetes 54 2109 2116 10.2337/diabetes.54.7.2109 15983212 (Pubitemid 40911274)
134. EW Heineke MB Johnson JE Dillberger, et al. 1993 Antioxidant MDL 29, 311 prevents diabetes in nonobese diabetic and multiple low-dose STZ-injected mice Diabetes 42 1721 1730 10.2337/diabetes.42.12.1721 8243818
135. JD Piganelli SC Flores C Cruz, et al. 2002 A metalloporphyrin-based superoxide dismutase mimic inhibits adoptive transfer of autoimmune diabetes by a diabetogenic T-cell clone Diabetes 51 347 355 10.2337/diabetes.51.2.347 11812741
136. M Hotta F Tashiro H Ikegami, et al. 1998 Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes J Exp Med 188 1445 1451 10.1084/jem.188.8.1445 9782121 (Pubitemid 28489581)
137. X Li H Chen PN Epstein 2006 Metallothionein and catalase sensitize to diabetes in nonobese diabetic mice: reactive oxygen species may have a protective role in pancreatic beta-cells Diabetes 55 1592 1604 10.2337/db05-1357 16731821 (Pubitemid 44324111)
138. J Irie A Shimada Y Oikawa, et al. 2004 N-acetyl-cysteine accelerates transfer of diabetes into non-obese diabetic scid mice Diabetologia 47 1803 1809 10.1007/s00125-004-1529-x 15502923 (Pubitemid 40022417)
139. BJ Goldstein K Mahadev X Wu 2005 Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets Diabetes 54 311 321 10.2337/diabetes.54.2.311 15677487
140. K Mahadev H Motoshima X Wu, et al. 2004 The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction Mol Cell Biol 24 1844 1854 10.1128/MCB.24.5.1844- 1854.2004 14966267 (Pubitemid 38248927)
141. A Castrillo OG Bodelon L Bosca 2000 Inhibitory effect of IGF-I on type 2 nitric oxide synthase expression in Ins-1 cells and protection against activation-dependent apoptosis: involvement of phosphatidylinositol 3-kinase Diabetes 49 209 217 10.2337/diabetes.49.2.209 10868937
142. W Chen KV Salojin QS Mi, et al. 2004 Insulin-like growth factor (IGF)-I/IGF-binding protein-3 complex: therapeutic efficacy and mechanism of protection against type 1 diabetes Endocrinology 145 627 638 10.1210/en.2003-1274 14617576 (Pubitemid 38183805)
143. M Harrison AM Dunger S Berg, et al. 1998 Growth factor protection against cytokine-induced apoptosis in neonatal rat islets of langerhans: role of Fas FEBS Lett 435 207 210 10.1016/S0014-5793(98)01051-5 9762910 (Pubitemid 28435001)
144. D Thomas H Yang DJ Boffa, et al. 2002 Proapoptotic Bax is hyperexpressed in isolated human islets compared with antiapoptotic Bcl-2 Transplantation 74 1489 1496 10.1097/00007890-200212150-00003 12490780 (Pubitemid 36014219)
145. H Kobayash R Doi R Hosotani, et al. 2000 Immunohistochemical analysis of apoptosis-related proteins in human embryonic and fetal pancreatic tissues Int J Pancreatol 27 113 122 10.1385/IJGC:27:2:113 10862510
146. P Naik J Karrim D Hanahan 1996 The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors Genes Dev 10 2105 2116 10.1101/gad.10.17.2105 8804306
147. P Dupraz C Rinsch WF Pralong, et al. 1999 Lentivirus-mediated Bcl-2 expression in betaTC-tet cells improves resistance to hypoxia and cytokine-induced apoptosis while preserving in vitro and in vivo control of insulin secretion Gene Ther 6 1160 1169 10.1038/sj.gt.3300922 10455420 (Pubitemid 29295223)
148. H Iwahashi T Hanafusa Y Eguchi, et al. 1996 Cytokine-induced apoptotic cell death in a mouse pancreatic beta-cell line: inhibition by Bcl-2 Diabetologia 39 530 536 10.1007/BF00403299 8739912
149. Y Liu A Rabinovitch W Suarez-Pinzon, et al. 1996 Expression of the bcl-2 gene from a defective HSV-1 amplicon vector protects pancreatic beta-cells from apoptosis Hum Gene Ther 7 1719 1726 10.1089/hum.1996.7.14-1719 8886842
150. A Rabinovitch W Suarez-Pinzon K Strynadka, et al. 1999 Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction Diabetes 48 1223 1229 10.2337/diabetes.48.6. 1223 10342808 (Pubitemid 29241018)
151. J Saldeen 2000 Cytokines induce both necrosis and apoptosis via a common Bcl-2-inhibitable pathway in rat insulin-producing cells Endocrinology 141 2003 2010 10.1210/en.141.6.2003 10830283 (Pubitemid 32274349)
152. RM Sutherland J Allison HE Thomas, et al. 2004 Bcl-2 protection of islet allografts is unmasked by costimulation blockade Transplantation 77 1610 1613 10.1097/01.TP.0000132283.95107.9C 15239630 (Pubitemid 38703046)
153. AR Barbu G Akusjarvi N Welsh 2002 Adenoviral-induced islet cell cytotoxicity is not counteracted by Bcl-2 overexpression Mol Med 8 733 741 12520090
154. VV Tran G Chen CB Newgard, et al. 2003 Discrete and complementary mechanisms of protection of beta-cells against cytokine-induced and oxidative damage achieved by bcl-2 overexpression and a cytokine selection strategy Diabetes 52 1423 1432 10.2337/diabetes.52.6.1423 12765953 (Pubitemid 36666197)
155. J Allison H Thomas D Beck, et al. 2000 Transgenic overexpression of human Bcl-2 in islet beta cells inhibits apoptosis but does not prevent autoimmune destruction Int Immunol 12 9 17 10.1093/intimm/12.1.9 10607745
156. L Farilla A Bulotta B Hirshberg, et al. 2003 Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets Endocrinology 144 5149 5158 10.1210/en.2003-0323 12960095 (Pubitemid 37476040)
157. F Ranta D Avram S Berchtold, et al. 2006 Dexamethasone induces cell death in insulin-secreting cells, an effect reversed by exendin-4 Diabetes 55 1380 1390 10.2337/db05-1220 16644695 (Pubitemid 44195377)
158. AM Shapiro JR Lakey EA Ryan, et al. 2000 Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen N Engl J Med 343 230 238 10.1056/NEJM200007273430401 10911004 (Pubitemid 30490390)
159. M Biarnes M Montolio V Nacher, et al. 2002 Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia Diabetes 51 66 72 10.2337/diabetes.51.1.66 11756324
160. BJ Hering R Kandaswamy JD Ansite, et al. 2005 Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes JAMA 293 830 835 10.1001/jama.293.7.830 15713772 (Pubitemid 40250366)
161. O Korsgren B Nilsson C Berne, et al. 2005 Current status of clinical islet transplantation Transplantation 79 1289 1293 10.1097/01.TP.0000157273. 60147.7C 15912090 (Pubitemid 40734785)
162. H Johansson A Lukinius L Moberg, et al. 2005 Tissue factor produced by the endocrine cells of the islets of langerhans is associated with a negative outcome of clinical islet transplantation Diabetes 54 1755 1762 10.2337/diabetes.54.6.1755 15919797 (Pubitemid 40770765)
163. L Moberg H Johansson A Lukinius, et al. 2002 Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation Lancet 360 2039 2045 10.1016/S0140-6736(02)12020- 4 12504401 (Pubitemid 36026584)
164. R Bottino AN Balamurugan H Tse, et al. 2004 Response of human islets to isolation stress and the effect of antioxidant treatment Diabetes 53 2559 2568 10.2337/diabetes.53.10.2559 15448084 (Pubitemid 39299262)
165. L Piemonti BE Leone R Nano, et al. 2002 Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation Diabetes 51 55 65 10.2337/diabetes.51.1.55 11756323
166. S Marzorati B Antonioli R Nano, et al. 2006 Culture medium modulates proinflammatory conditions of human pancreatic islets before transplantation Am J Transplant 6 2791 2795 10.1111/j.1600-6143.2006.01512.x 16939517 (Pubitemid 44571702)
167. A Pileggi RD Molano T Berney, et al. 2001 Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation Diabetes 50 1983 1991 10.2337/diabetes.50.9.1983 11522663
168. R Riachy B Vandewalle S Belaich, et al. 2001 Beneficial effect of 1, 25 dihydroxyvitamin D3 on cytokine-treated human pancreatic islets J Endocrinol 169 161 168 10.1677/joe.0.1690161 11250657 (Pubitemid 32273225)
169. Z Yang M Chen JD Ellett, et al. 2005 Inflammatory blockade improves human pancreatic islet function and viability Am J Transplant 5 475 483 10.1111/j.1600-6143.2005.00707.x 15707401 (Pubitemid 40313338)
170. H Wang SS Lee W Gao, et al. 2005 Donor treatment with carbon monoxide can yield islet allograft survival and tolerance Diabetes 54 1400 1406 10.2337/diabetes.54.5.1400 15855326 (Pubitemid 40586670)
171. EC Lewis L Shapiro OJ Bowers, et al. 2005 Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice Proc Natl Acad Sci USA 102 12153 12158 10.1073/pnas.0505579102 16093309 (Pubitemid 41291144)
172. A Langlois W Bietiger K Mandes, et al. 2008 Overexpression of vascular endothelial growth factor in vitro using deferoxamine: a new drug to increase islet vascularization during transplantation Transplant Proc 40 473 476 10.1016/j.transproceed.2008.01.003 18374106
173. H Hui N Khoury X Zhao, et al. 2005 Adenovirus-mediated XIAP gene transfer reverses the negative effects of immunosuppressive drugs on insulin secretion and cell viability of isolated human islets Diabetes 54 424 433 10.2337/diabetes.54.2.424 15677500
174. JA Emamaullee L Stanton C Schur, et al. 2007 Caspase inhibitor therapy enhances marginal mass islet graft survival and preserves long-term function in islet transplantation Diabetes 56 1289 1298 10.2337/db06-1653 17303806 (Pubitemid 46715609)
175. VR Sutton E Estella C Li, et al. 2006 A critical role for granzyme B, in addition to perforin and TNFalpha, in alloreactive CTL-induced mouse pancreatic beta cell death Transplantation 81 146 154 10.1097/01.tp.0000191939.68451.d9 16436955
176. JA Emamaullee AM Shapiro 2006 Interventional strategies to prevent beta-cell apoptosis in islet transplantation Diabetes 55 1907 1914 10.2337/db05-1254 16804057 (Pubitemid 44509961)
177. JL Contreras G Bilbao C Smyth, et al. 2001 Gene transfer of the Bcl-2 gene confers cytoprotection to isolated adult porcine pancreatic islets exposed to xenoreactive antibodies and complement Surgery 130 166 174 10.1067/msy.2001.115828 11490345 (Pubitemid 32721665)
178. ST Grey MB Arvelo WM Hasenkamp, et al. 1999 Adenovirus-mediated gene transfer of the anti-apoptotic protein A20 in rodent islets inhibits IL-1 beta-induced NO release Transplant Proc 31 789 10.1016/S0041-1345(98)01769-2 10083338 (Pubitemid 29127675)
179. M Prentki CJ Nolan 2006 Islet beta cell failure in type 2 diabetes J Clin Invest 116 1802 1812 10.1172/JCI29103 16823478 (Pubitemid 44033300)
180. MY Donath DJ Gross E Cerasi, et al. 1999 Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes Diabetes 48 738 744 10.2337/diabetes.48.4.738 10102689
181. A Pick J Clark C Kubstrup, et al. 1998 Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat Diabetes 47 358 364 10.2337/diabetes.47.3.358 9519740 (Pubitemid 28104196)
182. E Zini M Osto M Franchini, et al. 2009 Hyperglycaemia but not hyperlipidaemia causes beta cell dysfunction and beta cell loss in the domestic cat Diabetologia 52 336 346 10.1007/s00125-008-1201-y 19034421
183. M Federici M Hribal L Perego, et al. 2001 High glucose causes apoptosis in cultured human pancreatic islets of langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program Diabetes 50 1290 1301 10.2337/diabetes.50.6.1290 11375329
184. NN Danial LD Walensky CY Zhang, et al. 2008 Dual role of proapoptotic BAD in insulin secretion and beta cell survival Nat Med 14 144 153 10.1038/nm1717 18223655 (Pubitemid 351214557)
185. Y Tanaka PO Tran J Harmon, et al. 2002 A role for glutathione peroxidase in protecting pancreatic beta cells against oxidative stress in a model of glucose toxicity Proc Natl Acad Sci USA 99 12363 12368 10.1073/pnas.192445199 12218186
186. J Chen G Saxena IN Mungrue, et al. 2008 Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis Diabetes 57 938 944 10.2337/db07-0715 18171713
187. M Nakayama T Inoguchi T Sonta, et al. 2005 Increased expression of NAD(P)H oxidase in islets of animal models of type 2 diabetes and its improvement by an AT1 receptor antagonist Biochem Biophys Res Commun 332 927 933 10.1016/j.bbrc.2005.05.065 15922295 (Pubitemid 40798176)
188. JA Ehses A Perren E Eppler, et al. 2007 Increased number of islet-associated macrophages in type 2 diabetes Diabetes 56 2356 2370 10.2337/db06-1650 17579207 (Pubitemid 47358243)
189. K Maedler P Sergeev F Ris, et al. 2002 Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets J Clin Invest 110 851 860 12235117
190. K Maedler GA Spinas R Lehmann, et al. 2001 Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets Diabetes 50 1683 1690 10.2337/diabetes.50.8.1683 11473025
191. N Welsh M Cnop I Kharroubi, et al. 2005 Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or the type 2 diabetes milieu to human pancreatic islets? Diabetes 54 3238 3244 10.2337/diabetes.54.11.3238 16249450 (Pubitemid 43334380)
192. H Elouil AK Cardozo DL Eizirik, et al. 2005 High glucose and hydrogen peroxide increase c-Myc and haeme-oxygenase 1 mRNA levels in rat pancreatic islets without activating NFkappaB Diabetologia 48 496 505 10.1007/s00125-004- 1664-4 15739117 (Pubitemid 40487297)
193. DL Eizirik AK Cardozo M Cnop 2008 The role for endoplasmic reticulum stress in diabetes mellitus Endocr Rev 29 42 61 10.1210/er.2007-0015 18048764 (Pubitemid 351252746)
194. DR Laybutt AM Preston MC Akerfeldt, et al. 2007 Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes Diabetologia 50 752 763 10.1007/s00125-006-0590-z 17268797 (Pubitemid 46355827)
195. CJ Huang CY Lin L Haataja, et al. 2007 High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes Diabetes 56 2016 2027 10.2337/db07-0197 17475933 (Pubitemid 47201819)
196. S Zraika RL Hull J Udayasankar, et al. 2009 Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis Diabetologia 52 626 635 10.1007/s00125-008-1255-x 19148619
197. D Ron P Walter 2007 Signal integration in the endoplasmic reticulum unfolded protein response Nat Rev Mol Cell Biol 8 519 529 10.1038/nrm2199 17565364 (Pubitemid 46985379)
198. H Puthalakath LA O'Reilly P Gunn, et al. 2007 ER stress triggers apoptosis by activating BH3-only protein Bim Cell 129 1337 1349 10.1016/j.cell.2007.04.027 17604722 (Pubitemid 46962086)
199. H Zinszner M Kuroda X Wang, et al. 1998 CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum Genes Dev 12 982 995 10.1101/gad.12.7.982 9531536
200. MC Wei WX Zong EH Cheng, et al. 2001 Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death Science 292 727 730 10.1126/science.1059108 11326099 (Pubitemid 32385543)
201. YP Zhou JC Pena MW Roe, et al. 2000 Overexpression of Bcl-x(L) in beta-cells prevents cell death but impairs mitochondrial signal for insulin secretion Am J Physiol Endocrinol Metab 278 E340 E351 10662719
202. D Scheuner RJ Kaufman 2008 The unfolded protein response: a pathway that links insulin demand with beta-cell failure and diabetes Endocr Rev 29 317 333 10.1210/er.2007-0039 18436705 (Pubitemid 351679702)
203. CM Haynes EA Titus AA Cooper 2004 Degradation of misfolded proteins prevents ER-derived oxidative stress and cell death Mol Cell 15 767 776 10.1016/j.molcel.2004.08.025 15350220 (Pubitemid 39194906)
204. S Oyadomari A Koizumi K Takeda, et al. 2002 Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes J Clin Invest 109 525 532 11854325
205. HP Harding H Zeng Y Zhang, et al. 2001 Diabetes mellitus and exocrine pancreatic dysfunction in perk-/- mice reveals a role for translational control in secretory cell survival Mol Cell 7 1153 1163 10.1016/S1097-2765(01)00264-7 11430819 (Pubitemid 32607350)
206. AA Osman M Saito C Makepeace, et al. 2003 Wolframin expression induces novel ion channel activity in endoplasmic reticulum membranes and increases intracellular calcium J Biol Chem 278 52755 52762 10.1074/jbc.M310331200 14527944 (Pubitemid 38035873)
207. M Delepine M Nicolino T Barrett, et al. 2000 EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome Nat Genet 25 406 409 10.1038/78085 10932183 (Pubitemid 32983431)